{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:57:30Z","timestamp":1773842250409,"version":"3.50.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>It was shown that hypertension delays SARS CoV-2 viral clearance and exacerbates airway hyperinflammation in the respiratory tract. However, it is unknown whether hypertension determines the long-term cellular and humoral response to SARS Cov2. Health care workers (HCWs) after an outbreak of SARS Cov-2 infections were analyzed. Infected HCWs were not vaccinated before blood collection. 5-14 months (median 7 months) after detection of SARS CoV-2 infection, blood was taken to analyze humoral response (S1 IgG and SARS CoV-2 neutralizing antibodies) and cellular (T cell responses to SARS-CoV-2 with Lymphocyte Transformation Test). To identify clinical factors that determine the immune response, a multivariate regression analysis was done considering age, BMI, sex, diabetes, hypertension, smoking, COPD, asthma and time between PCR positivity and blood collection as confounding factors. Infected hypertensive HCWs more often needed to be hospitalized than non-hypertensive HCWs, but were less likely to develop anosmia and myalgia. The long-term humoral and cellular immune response was significantly strengthened in hypertensive versus normotensive infected HCWs. Multivariate regression analysis revealed that hypertension was independently associated with the humoral response to SARS CoV-2 infection. Multivariate regression analysis using same confounding factors for the humoral response showed a clear trend for an association with the cellular response to SARS CoV-2 infection as well. In conclusion, SARS CoV-2 infection strengthened  immune response to SARS CoV-2 infection in hypertensive HCWs independent of other risk factors.<\/jats:p>","DOI":"10.3389\/fimmu.2022.915001","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T09:06:09Z","timestamp":1662109569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection"],"prefix":"10.3389","volume":"13","author":[{"given":"Chang","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Sch\u00f6nbrunn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristin","family":"Klemm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"von Baehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard K.","family":"Kr\u00e4mer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saban","family":"Elitok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthold","family":"Hocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.610688","article-title":"Humoral responses and serological assays in SARS-CoV-2 infections","volume":"11","author":"Galipeau","year":"2020","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-00796-1","article-title":"Hypertension delays viral clearance and exacerbates airway hyperinflammation in patients with COVID-19","volume":"39","author":"Trump","year":"2021","journal-title":"Nat Biotechnol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002843","article-title":"2021 European Society of hypertension practice guidelines for office and out-of-office blood pressure measurement","volume":"39","author":"Stergiou","year":"2021","journal-title":"J Hypertens"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","volume":"587","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2022.05.025","article-title":"T-Cell proliferation assay for the detection of SARS-CoV-2-specific T-cells","volume":"532","author":"Chu","year":"2022","journal-title":"Clin Chim Acta"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3201\/eid2607.200841","article-title":"Severe acute respiratory syndrome coronavirus 2-specific antibody responses in coronavirus disease patients","volume":"26","author":"Okba","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0631-z","article-title":"A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction","volume":"38","author":"Tan","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1128\/MMBR.00024-15","article-title":"Deconstructing the antiviral neutralizing-antibody response: Implications for vaccine development and immunity","volume":"80","author":"VanBlargan","year":"2016","journal-title":"Microbiol Mol Biol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02438-20","article-title":"A new SARS-CoV-2 dual-purpose serology test: Highly accurate infection tracing and neutralizing antibody response detection","volume":"59","author":"Taylor","year":"2021","journal-title":"J Clin Microbiol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"114031","DOI":"10.1016\/j.jviromet.2020.114031","article-title":"Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma","volume":"288","author":"von Rhein","year":"2021","journal-title":"J Virol Methods"},{"key":"B11","doi-asserted-by":"publisher","first-page":"100928","DOI":"10.1016\/j.eclinm.2021.100928","article-title":"Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine","volume":"36","author":"Pellini","year":"2021","journal-title":"EClinicalMedicine"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00063.2013","article-title":"The immune system in hypertension","volume":"38","author":"Trott","year":"2014","journal-title":"Adv Physiol Educ"},{"key":"B13","article-title":"Passive transfer of autoimmune induced hypertension in the rat by lymph node cells","volume":"25","author":"Okuda","year":"1967","journal-title":"Tex Rep Biol Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000179322","article-title":"Autoimmune factors associated with infarction of the kidney","volume":"1","author":"White","year":"1964","journal-title":"Nephron"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the immune system in hypertension","volume":"97","author":"Rodriguez-Iturbe","year":"2017","journal-title":"Physiol Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14660","article-title":"Comparison of infection risks and clinical outcomes in patients with and without SARS-CoV-2 lung infection under renin-angiotensin-aldosterone system blockade: Systematic review and meta-analysis","volume":"87","author":"Chu","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1470320320926899","DOI":"10.1177\/1470320320926899","article-title":"Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression","volume":"21","author":"Pranata","year":"2020","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"B18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13098-020-00586-4","article-title":"Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis","volume":"12","author":"de Almeida-Pititto","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa057","article-title":"Hypertension and COVID-19","volume":"33","author":"Schiffrin","year":"2020","journal-title":"Am J Hypertens"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab191","article-title":"Hyperinflammation as underlying mechanism predisposing patients with cardiovascular diseases for severe COVID-19","volume":"42","author":"Landmesser","year":"2021","journal-title":"Eur Heart J"},{"key":"B21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with covid-19","volume":"384","author":"Group","year":"2021","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd9010015","article-title":"Renin angiotensin system blockers and risk of mortality in hypertensive patients hospitalized for COVID-19: An Italian registry","volume":"9","author":"Angeli","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.3594","article-title":"Association between renin-Angiotensin-Aldosterone system inhibitors and clinical outcomes in patients with COVID-19: A systematic review and meta-analysis","volume":"4","author":"Baral","year":"2021","journal-title":"JAMA Netw Open"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2020.09.004","article-title":"COVID-19 in-hospital mortality and use of renin-angiotensin system blockers in geriatrics patients","volume":"21","author":"Genet","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"100112","DOI":"10.1016\/j.ahjo.2022.100112","article-title":"Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab","volume":"13","author":"Smith","year":"2022","journal-title":"Am Heart J Plus"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.915001\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T09:06:12Z","timestamp":1662109572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.915001\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":25,"alternative-id":["10.3389\/fimmu.2022.915001"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.915001","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"article-number":"915001"}}